Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 68 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
671 15.1 months Advanced breast cancer 4 Biologic therapy
Royal Marsden Hospital United Kingdom 7/2003
Treatment Details: Patients: This Phase II study involved 76 patients with advanced breast cancer. Treatment: The treatment consisted of oral administration of an inhibitor of farnesyl transferase (R1157
 
672 15.1 months Metastatic colorectal cancer 3 Chemotherapy
Istituto Regina Elena Italy 11/2003
Treatment Details: Patients: This Phase II study involved 35 patients with metastatic colorectal cancer. All patients had received prior chemotherapy. Treatment: The treatment consisted of four chemothera
 
673 15.1 months Metastatic colorectal cancer 3 Chemotherapy
Istituto Regina Elena Italy 11/2003
Treatment Details: Patients: This Phase II study involved 35 patients with metastatic colorectal cancer. All patients had received prior chemotherapy. Treatment: The treatment consisted of four chemothera
 
674 15.1 months Metastatic, castration-resistant prostate cancer 5 Chemotherapy
Hormone
Royal Marsden NHS Foundation Trust and The Institute of Cancer Research United Kingdom 10/2010
Treatment Details: Patients: This phase 3 study involved men with metastatic castration-resistant prostate cancer. Patients were separated into two treatment groups. Group A consisted of 377 men with a medi
 
675 15.0 months Advanced NSCLC 4 Biologic therapy
Chemotherapy
Memorial Sloan-Kettering Cancer Center United States 1/2009
Treatment Details: Patients: This phase 2 study involved eighty-six patients with advanced non-small cell lung cancer. They ranged in age from 42 to 81 years of age. Treatment: Patients were treated wi
 
676 15.0 months Recurrent or persistent epithelial ovarian or primary peritoneal cancer 4 Chemotherapy
MD Anderson Cancer Center United States 6/2008
Treatment Details: Patients: This phase II study involved 26 women with recurrent or persistent epithelial ovarian or primary peritoneal cancer. The majority (16) were between the aged of 60 and 79 years of
 
677 15.0 months Metastatic breast cancer 4 Chemotherapy
Korea University Guro Hospital Korea 2/2006
Treatment Details: Patients: This phase II study involved 33 women with taxane resistant metastatic breast cancer. The median age was 56 years, ranging from 35-68. All patients had previously received a chem
 
678 15.0 months kidney (metastatic) 4 Immunotherapy
Hoag Cancer Center United States 4/2006
Treatment Details: Patients: This phase II trial involved 36 patients (25 men, 11 women) with metastatic kidney cancer. The median age was 57 years. Metastatic sites were lung, lymph nodes, bone, liver, adr
 
679 15.0 months Metastatic rcc 4 Immunotherapy
Hoag Cancer Hospital United States 4/2006
Treatment Details: Patients: This Phase II trial involved 36 patients with metastatic renal cell carcinoma. There were 25 men and 11 women and the median age was 57. Prior treatment included nephrectomy (31)
 
680 15.0 months Advanced colorectal carcinoma 5 Chemotherapy
Various Greece 1/2003
Treatment Details: Patients: This Phase II study involved 55 patients with advanced colorectal carcinoma. Treatment: Treatment consisted of three chemotherapy drugs irinotecan (camptosar, CPT-11), leucovo
 
Page 68 of 187  | Previous Page  | Next Page